Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial.

Autor: Mallick S; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India. drsupriyamallick@gmail.com., Gupta S; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Amariyil A; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Kunhiparambath H; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Laviraj MA; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Sharma S; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Sagiraju HKR; Department of Preventive Oncology, All India Institute of Medical Sciences, New Delhi, India., Julka PK; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Sharma D; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India., Rath GK; Department of Radiation Oncology, National Cancer Institute, All India Institute of Medical Sciences, New Delhi, India.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2023 Aug; Vol. 164 (1), pp. 141-146. Date of Electronic Publication: 2023 Jul 15.

Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).

Autor: Mallick S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India. drsupriyamallick@gmail.com., Kunhiparambath H; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Gupta S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Benson R; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Sharma S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Laviraj MA; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Upadhyay AD; Department of Bio-Statistics, All India Institute of Medical Sciences, New Delhi, India., Julka PK; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Sharma D; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Rath GK; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.

Publikováno v: Journal of neuro-oncology [J Neurooncol] 2018 Oct; Vol. 140 (1), pp. 75-82. Date of Electronic Publication: 2018 Jun 23.

Esthesioneuroblastoma with large intracranial extension treated with Induction chemotherapy, de-bulking surgery and image guided intensity modulated radiotherapy.

Autor: Giridhar P; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Mallick S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India. drsupriyamallick@gmail.com., Laviraj MA; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India., Bhasker S; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India.

Publikováno v: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery [Eur Arch Otorhinolaryngol] 2016 May; Vol. 273 (5), pp. 1323-5. Date of Electronic Publication: 2015 Jun 04.

Recurrent Bowen's disease of scalp treated with high dose rate surface mold brachytherapy: a case report and review of the literature.

Autor: Gandhi AK; Department of Radiation Oncology, All India Institute of Medical Sciences., Laviraj MA; Medical Physics, Department of Radiation Oncology, All India Institute of Medical Sciences., Kashyap L; Department of Radiation Oncology, All India Institute of Medical Sciences., Purkait S; Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India., Sharma DN; Department of Radiation Oncology, All India Institute of Medical Sciences., Julka PK; Department of Radiation Oncology, All India Institute of Medical Sciences., Rath GK; Department of Radiation Oncology, All India Institute of Medical Sciences.

Publikováno v: Journal of contemporary brachytherapy [J Contemp Brachytherapy] 2015 Jan; Vol. 6 (4), pp. 389-94. Date of Electronic Publication: 2014 Dec 31.

Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.

Autor: Gandhi AK; Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India. Electronic address: ajeetgandhi23@gmail.com., Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, Manigandan D, Laviraj MA, Kumar S, Thulkar S

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2013 Nov 01; Vol. 87 (3), pp. 542-8.